These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14985668)

  • 21. Intramuscular use of fosphenytoin: an overview.
    Uthman BM; Wilder BJ; Ramsay RE
    Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosphenytoin in infants.
    Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS
    J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of fosphenytoin.
    Fierro L; Hudak J
    Ann Emerg Med; 1998 Jan; 31(1):137-8; author reply 138-9. PubMed ID: 9437361
    [No Abstract]   [Full Text] [Related]  

  • 24. Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.
    Meek PD; Davis SN; Collins DM; Gidal BE; Rutecki PA; Burstein AH; Fischer JH; Leppik IE; Ramsay RE
    Arch Intern Med; 1999 Dec 13-27; 159(22):2639-44. PubMed ID: 10597754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA; Kao LS; Kozar R; Holcomb JB
    J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers.
    Tanaka J; Kasai H; Shimizu K; Shimasaki S; Kumagai Y
    Eur J Clin Pharmacol; 2013 Mar; 69(3):489-97. PubMed ID: 22918614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments.
    Mortimer D; Bosch M; Mckenzie JE; Turner S; Chau M; Ponsford JL; Knott JC; Gruen RL; Green SE
    Implement Sci; 2018 Dec; 13(1):147. PubMed ID: 30518430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery.
    Wilder BJ; Campbell K; Ramsay RE; Garnett WR; Pellock JM; Henkin SA; Kugler AR
    Arch Neurol; 1996 Aug; 53(8):764-8. PubMed ID: 8759983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients.
    Higuchi K; Yamashita D; Kashihara Y; Kakara M; Hirota T; Hirakawa M; Ieiri I
    Ther Drug Monit; 2019 Oct; 41(5):674-680. PubMed ID: 31095070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fosphenytoin for seizure control.
    Hutt N
    Am J Nurs; 1999 Mar; 99(3):52. PubMed ID: 10091570
    [No Abstract]   [Full Text] [Related]  

  • 32. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.
    Pieracci FM; Moore EE; Beauchamp K; Tebockhorst S; Barnett CC; Bensard DD; Burlew CC; Biffl WL; Stoval RT; Johnson JL
    J Trauma Acute Care Surg; 2012 Jan; 72(1):276-81. PubMed ID: 22310136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous administration of fosphenytoin: options for the management of seizures.
    Ramsay RE; DeToledo J
    Neurology; 1996 Jun; 46(6 Suppl 1):S17-9. PubMed ID: 8649609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-Dependent Decline in Serum Phenytoin Concentration With Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study.
    Ohno Y; Niwa T; Hirai K; Suzuki K; Yamada Y; Hayashi Y; Hayashi H; Suzuki A; Itoh Y
    Ther Drug Monit; 2018 Aug; 40(4):507-511. PubMed ID: 29683874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: phenytoin use and efficacy in the ED.
    Gallop K
    Emerg Med Australas; 2010 Apr; 22(2):108-18. PubMed ID: 20534046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
    Popławska M; Borowicz KK; Czuczwar SJ
    Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Kokwaro GO
    Br J Clin Pharmacol; 2002 Dec; 54(6):635-42. PubMed ID: 12492612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of fosphenytoin for benign convulsions with mild gastroenteritis.
    Nakazawa M; Toda S; Abe S; Ikeno M; Igarashi A; Nakahara E; Yamashita S; Niijima S; Shimizu T; Okumura A
    Brain Dev; 2015 Oct; 37(9):864-7. PubMed ID: 25708686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin.
    DeToledo JC; Lowe MR; Rabinstein A; Villaviza N
    Epilepsia; 2001 Feb; 42(2):288. PubMed ID: 11240605
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats.
    Burstein AH; Cox DS; Mistry B; Eddington ND
    Epilepsy Res; 1999 Apr; 34(2-3):129-33. PubMed ID: 10210027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.